TABLE 3

Odds ratios for failure of fibrinolysis and subgroup surgical referral, determined using a univariate logistic regression model

CovariateAdditional procedureSurgical referral
OR (95% CI)p-valueOR (95% CI)p-value
Urokinase versus t-PA/DNAse0.66 (0.28–1.59)0.360.59 (0.17–2.13)0.43
Age1 (0.97–1.02)0.950.99 (0.95–1.02)0.45
Positive bacterial culture1.71 (0.71–4.16)0.232 (0.59–6.79)0.27
Hospitalisation-to-drainage duration0.93 (0.85–1.01)0.070.87 (0.72–1.05)0.14
Drainage-to-lysis duration1.13 (0.93–1.36)0.221.19 (0.96–1.47)0.12
Non-image-guided versus image-guided procedure2.59 (0.89–7.56)0.080.88 (0.17–4.44)0.88
Tube size (ref. 8–12 French)
 14–18 French1.06 (0.4–2.78)0.911.54 (0.41–5.79)0.53
 20–24 French4.86 (1.26–18.77)0.021.72 (0.29–10.18)0.55
Duration of fibrinolysis1.18 (0.98–1.41)0.081.05 (0.83–1.33)0.66
Duration of drainage (ref. 1–3 days)
 4–10 days1.25 (0.31–5.1)0.760.57 (0.1–3.16)0.52
 >10 days6.75 (1.16–39.2)0.031.5 (0.2–11)0.69
Baseline area occupied by effusion (ref. ≤1/3)
 1/3 to 2/3 of the hemithorax2.94 (1.02–8.5)0.041.69 (0.4–7.1)0.47
 >2/3 of the hemithorax4.33 (1.1–17.1)0.041.61 (0.24–10.9)0.49
One versus multiple collections4.81 (1.48–15.66)0.0092.53 (0.49–11.82)0.31
Isolated versus grouped collections1.27 (0.43–3.69)0.672.45 (0.47–12.78)0.29

t-PA: tissue plasminogen activator.